Skip to main navigation Skip to search Skip to main content

A Multicenter, Randomized, Placebo Controlled, Double-Blind, Parallel Group & Event Driven Phase 3

Project: Research

Project Details

StatusFinished
Effective start/end date09/11/2309/10/25

Funding

  • Bayer Healthcare Pharmaceuticals Incorporated: $59.63